ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1066

Capillaroscopic Findings in Autoimmune Connective Tissue Diseases: Results from 20 Years of Experience in a Training Referral Center

Elvis Hysa, Carmen Pizzorni, Silvia Sammori, Emanuele Gotelli, Andrea Pogna, andrea cere, Carlotta Schenone, Veronica Gerli, sabrina Paolino, Alberto Sulli and Maurizio Cutolo, Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino Polyclinic Hospital, Genova, Italy

Meeting: ACR Convergence 2022

Keywords: antiphospholipid syndrome, autoimmune diseases, dermatomyositis, Sjögren's syndrome, Systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Systemic Sclerosis and Related Disorders – Clinical Poster I

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Nailfold videocapillaroscopy (NVC) allows the safe and fast detection of different microvascular patterns in patients affected by autoimmune connective tissue diseases (CTDs). The prevalence of the morphological microcirculatory alterations was retrospectively evaluated in a wide cohort of patients with Raynaud’s phenomenon secondary to a CTD at the time of the first single NVC, independently from their current treatment.

Methods: One-thousand-one-hundred-eighty-one (1181) patients affected by CTDs (1065 females, mean age 54.1 ± 16.2, mean disease duration 4.5 years ± 3) were included from 2001 to 2021. The considered CTDs, diagnosed through the classification criteria available at the time of the diagnosis, were: systemic sclerosis (SSc), undifferentiated connective tissue disease (UCTD), mixed connective tissue disease (MCTD), dermatomyositis (DM), systemic lupus erythematosus (SLE), Sjogren’s syndrome (SS) and primary anti-phospholipid syndrome (aPS) (for distribution see Table 1). The capillaroscopic parameters were collected according to the Fast Track Algorithm and distinguished between scleroderma-pattern (specific NVC alterations) and non-scleroderma patterns (non-specific NVC alterations) [1]. The presence of specific NVC findings detectable with a progressive presentation in SSc patients (“early”, “active”, “late” patterns) have been searched also in other CTDs beyond SSc. Scleroderma-like pattern was defined if the abnormalities observed in the three SSc NVC patterns were found mixed together at the same time [2]. The statistical analysis was performed with DATAtab®.

Results: Giant capillaries, capillary dilations and microhaemorrages were significantly more frequent in SSc and DM than in other CTDs (respectively in 73%, 99% and 70% of SSc patients e in 73%, 96% e 70% of DM patients). The specific abnormalities of capillary morphology, such as the ramifications (expression of neoangiogenesis) were significantly more frequent in SSc, MCTD and APS among all the CTDs (respectively, in 48%, 41% and 36% of cases). Moreover, giant capillaries and angiogenesis were also detected in MCTD (specifically, in 61% and 41% of cases). In APS patients, the most significant prevalence of microhaemorrages (50%) was observed compared with other CTDs, to the exclusion of SSc and DM being detectable in 70% of cases.

Among CTDs, the mean capillary density (1 linear mm) was significantly lower in SSc, DM and MCTD (respectively, 7.04 ± 0.18 vs 6.5 ± 0.75 vs 7.7 ± 0.48) compared with other CTDs. “Early”, “active” and “late” scleroderma patterns were detected in 34%, 38% and 16% of SSc patients whereas scleroderma-like pattern was found significantly more frequent in DM (63 %) and MCTD (37%).

Conclusion: Our data confirm that SSc and DM NVC analysis show a microangiopathy with a high prevalence of specifically diagnostic severe alterations compared with other CTDs. However, the microvascular alterations detected in other CTDs seem to further indicate that endothelial damage play an important role in their pathophysiology, worthy of frequent NVC evaluation.

References: 1. Smith V et al. Autoimmun Rev 2019 2. Cutolo M et al. Nature Rev Rheumatol 2021

Supporting image 1

Table 1. Capillaroscopic findings in autoimmune connective tissue diseases at baseline. Abbreviations: normal (NL), non-specific alterations (NSA)


Disclosures: E. Hysa, None; C. Pizzorni, None; S. Sammori, None; E. Gotelli, None; A. Pogna, None; a. cere, None; C. Schenone, None; V. Gerli, None; s. Paolino, None; A. Sulli, LABORATORY BALDACCI SPA; M. Cutolo, Bristol-Myers Squibb(BMS), Boehringer-Ingelheim, Amgen.

To cite this abstract in AMA style:

Hysa E, Pizzorni C, Sammori S, Gotelli E, Pogna A, cere a, Schenone C, Gerli V, Paolino s, Sulli A, Cutolo M. Capillaroscopic Findings in Autoimmune Connective Tissue Diseases: Results from 20 Years of Experience in a Training Referral Center [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/capillaroscopic-findings-in-autoimmune-connective-tissue-diseases-results-from-20-years-of-experience-in-a-training-referral-center/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/capillaroscopic-findings-in-autoimmune-connective-tissue-diseases-results-from-20-years-of-experience-in-a-training-referral-center/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology